Tourmaline Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $40 | $0 |
Gross Profit | -12 | 20 | -10 | |
EBITDA | -25,974 | -26,231 | -25,836 | -24,428 |
EBIT | -26,243 | -25,845 | -24,438 | |
Net Income | -23,092 | -22,970 | -22,235 | -20,177 |
Net Change In Cash | 0 | 0 | 40 | 0 |
Free Cash Flow | -20,271 | -21,688 | -20,898 | -23,444 |
Cash | 31,423 | 35,330 | 30,506 | 35,008 |
Basic Shares | 25,755 | 25,692 | 25,796 | 25,767 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -39 | -33 | -6 |
EBITDA | -89,732 | -45,376 | -19,695 |
EBIT | -73,210 | -45,409 | -19,701 |
Net Income | -73,210 | -42,124 | -19,701 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -77,272 | -28,137 | -11,526 |
Cash | 30,506 | 140,726 | 8,258 |
Basic Shares | 25,348 | 4,747 | 20,336 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.79 |
2025-03-31 | -$0.89 |
2024-12-31 | -$0.86 |
2024-09-30 | -$0.78 |
